1. Home
  2. CMRE vs EYPT Comparison

CMRE vs EYPT Comparison

Compare CMRE & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$15.32

Market Cap

1.8B

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.96

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRE
EYPT
Founded
1974
1987
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
CMRE
EYPT
Price
$15.32
$16.96
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$29.60
AVG Volume (30 Days)
489.7K
1.1M
Earning Date
02-04-2026
11-05-2025
Dividend Yield
3.02%
N/A
EPS Growth
N/A
N/A
EPS
2.51
N/A
Revenue
$2,085,335,000.00
$42,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.09
N/A
Revenue Growth
79.87
N/A
52 Week Low
$6.63
$3.91
52 Week High
$16.40
$19.11

Technical Indicators

Market Signals
Indicator
CMRE
EYPT
Relative Strength Index (RSI) 55.01 63.72
Support Level $15.02 $15.81
Resistance Level $15.88 $17.40
Average True Range (ATR) 0.39 1.02
MACD -0.18 0.00
Stochastic Oscillator 24.64 62.00

Price Performance

Historical Comparison
CMRE
EYPT

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: